Evidence map›Paper›PMID 32516967›Full record

ArticleInternational journal of molecular sciences2020

Anticancer and Antiangiogenic Activities of Novel α-Mangostin Glycosides in Human Hepatocellular Carcinoma Cells via Downregulation of c-Met and HIF-1α.

Sung Min Kim, Jang Mi Han, Tuoi Thi Le, Jae Kyung Sohng, Hye Jin Jung

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sung Min KimDepartment of Pharmaceutical Engineering and Biotechnology, Sun Moon University, Asan 31460, Korea.
Jang Mi HanDepartment of Life Science and Biochemical Engineering, Sun Moon University, Asan 31460, Korea.
Tuoi Thi LeDepartment of Life Science and Biochemical Engineering, Sun Moon University, Asan 31460, Korea.
Jae Kyung SohngDepartment of Pharmaceutical Engineering and Biotechnology, Sun Moon University, Asan 31460, Korea.ORCID 0000-0003-1583-5046
Hye Jin JungDepartment of Pharmaceutical Engineering and Biotechnology, Sun Moon University, Asan 31460, Korea.ORCID 0000-0003-3145-9300
Sun Moon University · KR

Funding

Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education NRF-2016R1D1A1B03932956NRF grant funded by the Ministry of Science and ICT NRF-2019R1A2C1009033
6 · The paper itself

Abstract

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and is a leading cause of cancer-related death worldwide. Therefore, exploring effective anticancer agents and their modes of action is essential for the prevention and treatment of HCC. Glycosylation can significantly improve the physicochemical and biological properties of small molecules, such as high solubility, stability increase, and lower toxicity. In the present study, for the first time, we evaluated the anticancer and antiangiogenic activities of α-mangostin-3-

Indexed as

Angiogenesis InhibitorsAntineoplastic AgentsApoptosisCarcinoma, HepatocellularCell Cycle CheckpointsCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticGlycosidesHumansHypoxia-Inducible Factor 1, alpha SubunitLiver NeoplasmsMolecular StructureNeoplastic Stem CellsProto-Oncogene Proteins c-metXanthonesAngiogenesis InhibitorsAntineoplastic AgentsGlycosidesHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitmangostinProto-Oncogene Proteins c-metXanthonesapoptosisautophagycancer stemnessc-Methepatocellular carcinomaHIF-1αtumor angiogenesisα-mangostin glycosides

Identifiers

PMID32516967
PMCPMC7312821
OpenAlexW3033185130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.